An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Drug Acquiring Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Followers are urged to contact these profiles privately for source information, while also obtaining promotional offers.
Thriving Trade on Social Networks
Separately, a robust market exists on Telegram, where groups with thousands of members share comparison photos, administration instructions and assertions of rapid British shipping. Sellers market the drug there before redirecting customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could result in individuals administering substances of unknown origin.
Some experts said the demand for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the British medical regulations.
Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer laws, risking penalties, legal action or prison.
Service Response and Content Removal
Based on TikTok, the service has taken down problematic content and prohibited associated keywords and query recommendations. The organization stated it was committed to keeping the platform safe and investing in strengthening enforcement strategies.
Online Trading Operations
Research also found communities with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, filled with images of slimming results, positive testimonials and detailed instructions for preparing or injecting at residence.
After minutes of entering one community, a vendor posted WhatsApp details, where most transactions occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or past usage.
Item Details and Pricing
Inside these groups, messages display black plastic parcels with Royal Mail labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.
Service Oversight and Safety Measures
A representative for the messaging service said it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering substances they cannot confirm. Although the research behind this drug is sound, these online products may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.
Her team has already encountered individuals injured by personal administration from unverified sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company experimental substance not yet approved … may expose patients to potentially significant medical dangers”.
